Used as a key intermediate in the synthesis of pharmaceutical agents, particularly in the development of central nervous system (CNS) active compounds. Its structure supports the creation of selective receptor modulators, especially for neurological and psychiatric disorders such as anxiety, depression, and schizophrenia. The compound's halogenated aromatic core enhances binding affinity to certain neurotransmitter receptors, making it valuable in medicinal chemistry for optimizing drug potency and metabolic stability. It is primarily employed in research settings for designing novel therapeutics with improved pharmacokinetic profiles.